CD80 Antibody [11C12]
Product Specifications
Background
CD80 Antibody: CD80, also known as B7-1, is a type I membrane protein that is a member of the immunoglobulin superfamily. Like the related protein CD86, this protein is expressed by antigen-presenting cells, and is the ligand for two proteins at the cell surface of T cells, CD28 and the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) . Binding of this protein with CD28 antigen is a costimulatory signal for activation of the T-cell and induces T-cell proliferation and cytokine production. CTLA-4 binding negatively regulates T-cell activation and diminishes the immune response (1) . Blocking the CTLA-4-CD80/CD86 interaction has been shown to enhance T-cell functions in acute lymphoblastomic leukemia (ALL), suggesting that this pathway may be an attractive target for future cancer immunotherapy (2) .
NCBI Gene ID
941
Swiss Prot
P33681
Accession Number
NP_005182
Host
Mouse
Reactivity
Human
Immunogen
CD80 antibody was raised against the extracellular domain of human CD80.
Clonality
Monoclonal
Clone
11C12
Conjugation
Unconjugated
Type
Primary Antibodies
Field of Research
Immunology
Purification
CD80 Antibody is supplied as protein A purified IgG1.
Positive Control
Cat. No. 1340 - Human Stomach Carcinoma Tissue Lysate
Concentration
1 mg/mL
Buffer
CD80 Antibody is supplied in PBS containing 0.02% sodium azide and 50% glycerol.
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
CD80 antibody can be stored at 4˚ C for three months and -20˚ C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Product Datasheet
https://www.prosci-inc.com/?datasheet_sku=RF16045
Fragment
IgG1
Symbol
CD80
Positive Control 2
Cat. No. 1315 - Human Tonsil Tissue
NCBI Official Name
CD80 molecule
NCBI Organism
Homo sapiens
Background Reference 01
Lane P. Regulation of T and B cell responses by modulating interactions between CD28/CTLA-4 and their ligands, CD80 and CD86. Ann NY Acad Sci 1997; 815:392-400.
Background Reference 02
Feucht J, Kayser S, Gorodezki D, et al. T-cell responses against CD19+ pediatric acute lymphoblastic leukemia mediated by bispecific T-cell engager (BiTE) are regulated contrarily by PD-L1 and CD80/CD86 on leukemic blasts. Oncotarget 2016; 7:76902-19.
Other Product Names
CD80 Antibody: CD80 molecule, B7, BB1, B7-1, B7.1, LAB7, CD28LG, CD28LG1
Tested Applications
ELISA, WB, IHC-P, ICC, IF
Protein ID
4885123
Physical Properties
Liquid
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items